Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for Cancer

por Raninga, Prahlad V., Trapani, Giovanna Di, Tonissen, Kathryn F.
Publicado 2014

Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma

por Raninga, Prahlad V., Di Trapani, Giovanna, Vuckovic, Slavica, Tonissen, Kathryn F.
Publicado 2016

Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma

por Raninga, Prahlad V., Di Trapani, Giovanna, Vuckovic, Slavica, Bhatia, Maneet, Tonissen, Kathryn F.
Publicado 2015

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment

por Clapper, Erin, Wang, Sicong, Raninga, Prahlad V., Di Trapani, Giovanna, Tonissen, Kathryn F.
Publicado 2020

Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma

por Raninga, Prahlad V., Trapani, Giovanna Di, Vuckovic, Slavica, Bhatia, Maneet, Tonissen, Kathryn F.
Publicado 2021

Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma

por Sze, Jun Hui, Raninga, Prahlad V., Nakamura, Kyohei, Casey, Mika, Khanna, Kum Kum, Berners-Price, Susan J., Di Trapani, Giovanna, Tonissen, Kathryn F.
Publicado 2019

CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors

por Lu, Xue, He, Yaowu, Johnston, Rebecca L., Nanayakarra, Devathri, Sankarasubramanian, Sivanandhini, Lopez, J. Alejandro, Friedlander, Michael, Kalimutho, Murugan, Hooper, John D., Raninga, Prahlad V., Khanna, Kum Kum
Publicado 2022

Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition

por Raninga, Prahlad V., Lee, Andy, Sinha, Debottam, Dong, Lan-feng, Datta, Keshava K., Lu, Xue, Kalita-de Croft, Priyakshi, Dutt, Mriga, Hill, Michelle, Pouliot, Normand, Gowda, Harsha, Kalimutho, Murugan, Neuzil, Jiri, Khanna, Kum Kum
Publicado 2020

RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC

por Kim, Seong-Jin, Ju, Jin-Sung, Kang, Myoung-Hee, Won, Ji Eun, Kim, Young Ha, Raninga, Prahlad V, Khanna, Kum Kum, Győrffy, Balázs, Pack, Chan-Gi, Han, Hee-Dong, Lee, Hee Jin, Gong, Gyungyub, Shin, Yong, Mills, Gordon B., Eyun, Seong-il, Park, Yun-Yong
Publicado 2020